These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19858440)

  • 21. The relation between vitamin D deficiency and fibromyalgia syndrome in women.
    Matthana MH
    Saudi Med J; 2011 Sep; 32(9):925-9. PubMed ID: 21894355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitamin D deficiency and supplementation in the elderly. A comparative trial of various modalities of administrating vitamin D2].
    Sebert JL; Fardellone P; Liu S; Ruiz JC; Bellony R; Cohen-Solal M; Perdu V; Defrance D
    Rev Rhum Mal Osteoartic; 1988; 55(9):693-700. PubMed ID: 3055249
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
    Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
    Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paricalcitol for reduction of albuminuria in diabetes.
    Delanaye P; Mariat C; Krzesinski JM; Cavalier E
    Lancet; 2011 Feb; 377(9766):635, author reply 636-7. PubMed ID: 21334526
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
    Tentori F; Hunt WC; Stidley CA; Rohrscheib MR; Bedrick EJ; Meyer KB; Johnson HK; Zager PG;
    Kidney Int; 2006 Nov; 70(10):1858-65. PubMed ID: 17021609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D₂) or cholecalciferol (D₃) in alcoholic liver cirrhosis.
    Malham M; Peter Jørgensen S; Lauridsen AL; Ott P; Glerup H; Dahlerup JF
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):172-8. PubMed ID: 22027703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normocalcemia in the Face of Marked Hypervitaminosis D: The Utility of Vitamin D Metabolite Profiling.
    Griffin TP; Murray H; Blake L; Griffin DG; Bell M; Mulkerrin E; O'Shea PM
    J Appl Lab Med; 2019 Sep; 4(2):264-269. PubMed ID: 31639673
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.
    Boyle MP; Noschese ML; Watts SL; Davis ME; Stenner SE; Lechtzin N
    Am J Respir Crit Care Med; 2005 Jul; 172(2):212-7. PubMed ID: 15860755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for vitamin D deficiency in the elderly.
    Kositsawat J; Geraci SA
    J Miss State Med Assoc; 2010 Jan; 51(1):7-10. PubMed ID: 20827865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
    Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
    Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
    Rastelli AL; Taylor ME; Gao F; Armamento-Villareal R; Jamalabadi-Majidi S; Napoli N; Ellis MJ
    Breast Cancer Res Treat; 2011 Aug; 129(1):107-16. PubMed ID: 21691817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of vitamin D deficiency: divergence between clinical practice and expert advice.
    Findlay M; Anderson J; Roberts S; Almond A; Isles C
    Postgrad Med J; 2012 May; 88(1039):255-60. PubMed ID: 22362902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
    Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
    Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Skeletal and extra-skeletal consequences of vitamin D deficiency].
    Szabó A
    Orv Hetil; 2011 Aug; 152(33):1312-9. PubMed ID: 21824858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving vitamin D levels in hospitalized individuals at risk of falls.
    Prater J; Greene GR; Rowland DY; Chaiban JT
    J Am Geriatr Soc; 2014 Oct; 62(10):1984-6. PubMed ID: 25333536
    [No Abstract]   [Full Text] [Related]  

  • 38. Cholecalciferol, not ergocalciferol, should be used for vitamin D supplementation.
    Grant WB
    Age Ageing; 2006 Nov; 35(6):645; author reply 645. PubMed ID: 16982666
    [No Abstract]   [Full Text] [Related]  

  • 39. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
    Lark RK; Lester GE; Ontjes DA; Blackwood AD; Hollis BW; Hensler MM; Aris RM
    Am J Clin Nutr; 2001 Mar; 73(3):602-6. PubMed ID: 11237938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paricalcitol for reduction of albuminuria in diabetes.
    Ortiz A; Sanchez Niño MD; Rojas J; Egido J
    Lancet; 2011 Feb; 377(9766):635-6, author reply 636-7. PubMed ID: 21334525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.